Two Sigma Securities »

Lucid Diagnostics shares owned by Two Sigma Securities

Quarter-by-quarter ownership of Lucid Diagnostics (LUCD) shares owned by Two Sigma Securities from 13F filings

Historical chart of Two Sigma Securities investment in Lucid Diagnostics

Tip: Access up to 7 years of quarterly data

All positions including Lucid Diagnostics held by Two Sigma Securities consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lucid Diagnostics by Two Sigma Securities

Quarter filed Position value Share count Share price at filing
2024-06-30 $23k 28k 0.82

More positions owned by Two Sigma Securities

NVIDIA Corporation Call Option (NVDA)
Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Meta Platforms Cl A Call Option (META)
Apple Call Option (AAPL)
Advanced Micro Devices (AMD)
Microsoft Corporation Call Option (MSFT)
Intel Corporation Call Option (INTC)
Eli Lilly & Co. Call Option (LLY)
Johnson & Johnson (JNJ)
JPMorgan Chase & Co. (JPM)
Tesla Motors (TSLA)
Palo Alto Networks Call Option (PANW)
Chevron Corporation Call Option (CVX)
Amazon (AMZN)
Costco Wholesale Corporation Call Option (COST)

View all positions for Two Sigma Securities

Top funds holding Lucid Diagnostics

Luminus Management
Vanguard Group
Geode Capital Management
Nantahala Capital Management
Lido Advisors
Levin Capital Strategies
LPL Financial
Verition Fund Management
Geneos Wealth Management
Two Sigma Securities
BlackRock
BlackRock
State Street Corporation
Tower Research Capital
Northern Trust

View all funds holding Lucid Diagnostics